Postcholecystectomy Syndrome

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 294 Experts worldwide ranked by ideXlab platform

V. V. Prysiazhniuk - One of the best experts on this subject based on the ideXlab platform.

M. Y. Nychytailo - One of the best experts on this subject based on the ideXlab platform.

M. S. Zahriichuk - One of the best experts on this subject based on the ideXlab platform.

A. I. Hutsuliak - One of the best experts on this subject based on the ideXlab platform.

John E. Kellow - One of the best experts on this subject based on the ideXlab platform.

  • Abnormal sphincter of oddi response to cholecystokinin in Postcholecystectomy Syndrome patients with irritable bowel Syndrome
    Digestive Diseases and Sciences, 1995
    Co-Authors: Peter R. Evans, John F. Dowsett, Young-tae Bak, Yiu-kay Chan, John E. Kellow
    Abstract:

    Standard biliary manometry, including cholecystokinin (CCK) provocation, was performed on 42 consecutive patients (36 F, 6 M, median age 45 years) with Postcholecystectomy Syndrome (PCS) who had no evidence of organic disease but who had objective clinical features suggesting sphincter of Oddi dysfunction (SOD) (classes I and II). Patients were subdivided into those with ( N =14) and without ( N =28) irritable bowel Syndrome (IBS) using a validated symptom questionnaire based on the modified Rome criteria. Resting sphincter of Oddi (SO) motor parameters (basal pressure, contractile amplitude and frequency, and proportion of retrograde contractions), the presence of abnormal manometry, and the presence of an abnormal response to CCK were compared in the two groups. No significant differences in resting parameters of SO motor activity between patients with and without IBS were observed, and abnormal biliary manometry as a whole was not more prevalent in either group (8/13 and 18/27, respectively). An abnormal response to CCK (failure of complete inhibition of phasic contractions), however, was demonstrated in five of 12 patients with IBS compared with only one of 23 patients without IBS ( P =0.01). In patients with Postcholecystectomy SOD, an abnormal response of the SO to CCK thus appears to be an important feature of the subset of patients with concomitant IBS.

  • Abnormal sphincter of Oddi response to cholecystokinin in Postcholecystectomy Syndrome patients with irritable bowel Syndrome. The irritable sphincter.
    Digestive diseases and sciences, 1995
    Co-Authors: Peter R. Evans, John F. Dowsett, Young-tae Bak, Yiu-kay Chan, John E. Kellow
    Abstract:

    Standard biliary manometry, including cholecystokinin (CCK) provocation, was performed on 42 consecutive patients (36 F, 6 M, median age 45 years) with Postcholecystectomy Syndrome (PCS) who had no evidence of organic disease but who had objective clinical features suggesting sphincter of Oddi dysfunction (SOD) (classes I and II). Patients were subdivided into those with (N=14) and without (N=28) irritable bowel Syndrome (IBS) using a validated symptom questionnaire based on the modified Rome criteria. Resting sphincter of Oddi (SO) motor parameters (basal pressure, contractile amplitude and frequency, and proportion of retrograde contractions), the presence of abnormal manometry, and the presence of an abnormal response to CCK were compared in the two groups. No significant differences in resting parameters of SO motor activity between patients with and without IBS were observed, and abnormal biliary manometry as a whole was not more prevalent in either group (8/13 and 18/27, respectively). An abnormal response to CCK (failure of complete inhibition of phasic contractions), however, was demonstrated in five of 12 patients with IBS compared with only one of 23 patients without IBS (P=0.01). In patients with Postcholecystectomy SOD, an abnormal response of the SO to CCK thus appears to be an important feature of the subset of patients with concomitant IBS.